Efficacy, safety, and adherence of tocilizumab therapy in elderly patients with rheumatoid arthritis: A real-world observational study
Objective: We evaluated the efficacy, safety, and drug survival rate of tocilizumab in the elderly patients with rheumatoid arthritis (RA). Methods: This study was conducted in 108 RA patients who started tocilizumab between 2008 and 2018. The patients were divided into a young group (<65 years)...
Guardado en:
Autores principales: | Yoshinobu Nakao, Yu Funakubo Asanuma, Takuma Tsuzuki Wada, Mayumi Matsuda, Hiroaki Yazawa, Yoshihiro Yoshida, Akira Todoriki, Ayumi Shintani, Toshihide Mimura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40bf5bde4d984b6b9bd4dfa2440ba935 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of tocilizumab in the treatment of rheumatoid arthritis
por: Yasuaki Okuda
Publicado: (2008) -
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid M, et al.
Publicado: (2011) -
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
por: Sho Mokuda, et al.
Publicado: (2013) -
Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
por: Sato T, et al.
Publicado: (2014) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka T, et al.
Publicado: (2014)